首页|期刊导航|药物分析学报(英文)|E3 ubiquitin ligase FBXW11-mediated downregulation of S100A11 promotes sensitivity to PARP inhibitor in ovarian cancer
药物分析学报(英文)2025,Vol.15Issue(7):1652-1666,15.DOI:10.1016/j.jpha.2025.101246
E3 ubiquitin ligase FBXW11-mediated downregulation of S100A11 promotes sensitivity to PARP inhibitor in ovarian cancer
E3 ubiquitin ligase FBXW11-mediated downregulation of S100A11 promotes sensitivity to PARP inhibitor in ovarian cancer
摘要
关键词
FBXW11/S100A11/PARPi resistance/Ovarian cancerKey words
FBXW11/S100A11/PARPi resistance/Ovarian cancer引用本文复制引用
Ligang Chen,Biliang Chen,Yi Ru,Xiaohui Lv,Mingyi Wang,Yunge Gao,Yanhong Lv,Lianghao Zhai,Jian Dong,Yan Chen,Xia Li,Xin Guo..E3 ubiquitin ligase FBXW11-mediated downregulation of S100A11 promotes sensitivity to PARP inhibitor in ovarian cancer[J].药物分析学报(英文),2025,15(7):1652-1666,15.基金项目
The present study was supported by the National Natural Sci-ence Foundation of China(Grant Nos.:81972440 and 82002740)and the Natural Science Foundation of Shaanxi Province,China(Grant No.:2024JC-ZDXM-52). (Grant Nos.:81972440 and 82002740)